Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma

Cancer Chemotherapy and Pharmacology

Volumn 73, Issue 1, 2014, Pages 53-60

  Ando, Hitoshi ^a   Natsume, Atsushi ^a   Senga, Takeshi ^b   Watanabe, Reiko ^c   Ito, Ichiro ^c   Ohno, Masasuke ^a   Iwami, Kenichiro ^a   Ohka, Fumiharu ^a   Motomura, Kazuya ^a   Kinjo, Sayano ^a   Ito, Maki ^a   Saito, Kiyoshi ^d   Morgan, Richard ^e   Wakabayashi, Toshishiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

HOXA9; HXR9 peptide; Meningioma

Indexed keywords

DNA; HXR9 PEPTIDE; PEPTIDE; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN TISSUE; CANCER INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TUMOR CELL LINE; TUMOR GROWTH;

EID: 84892825259     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2316-5     Document Type: Article

References (32)

1. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T (2006) Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 15:797-802
2. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60
3. Andrae N, Kirches E, Hartig R, Haase D, Keilhoff G, Kalinski T, Mawrin C (2012) Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells. Euro J Cancer 48:1831-1841
4. Backer-Grøndahl T, Moen BH, Torp SH (2012) The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 5:231
5. Cantile M, Procino A, D'Armiento M, Cindolo L, Cillo C (2003) HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis. J Cell Physiol 194:225-236
6. Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, Reis RM, Costello JF (2010) Reversing HOXA9 oncogene activation by PI3 K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res 70:453-462
7. Daniels TR, Neacato II, Rodriguez JA, Pandha HS, Morgan R, Penichet ML (2010) Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leuk Off J Leuk Soc Am Leuk Res Fund U.K 24:1555-1565
8. Durston AJ (2011) Hox homeotic selector genes: key regulators of embryogenesis. WebmedCentral EMBRYOLOGY 2:WMC002573
9. Eichhorst ST, Muller M, Li-Weber M, Schulze-Bergkamen H, Angel P, Krammer PH (2000) A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 20:7826-7837
10. Eklund EA (2007) The role of HOX genes in malignant myeloid disease. Cur Opin Hematol 14:85-89
11. Grier D, Thompson A, Kwasniewska A, McGonigle G, Halliday H, Lappin T (2005) The pathophysiology of HOX genes and their role in cancer. J Pathol 205:154-171
12. Hoegg S, Meyer A (2005) Hox clusters as models for vertebrate genome evolution. Trends Genet 21:421-424
13. Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C, Robertson G, MacDonald J, Cezard T, Bilenky M, Thiessen N, Zhao Y, Zeng T, Hirst M, Hero A, Jones S, Hess JL (2012) Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 119:388-398
14. Iimura T, Pourquié O (2007) Hox genes in time and space during vertebrate body formation. Dev Growth Differ 49:265-275
15. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR (1998) DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1:543-551
16. Kishida Y, Natsume A, Kondo Y, Takeuchi I, An B, Okamoto Y, Shinjo K, Saito K, Ando H, Ohka F (2012) Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Carcinogenesis 33:436-441
17. Ko SY, Barengo N, Ladanyi A, Lee JS, Marini F, Lengyel E, Naora H (2012) HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. J Clin Investig 122:3603-3617
18. Laurent A, Bihan R, Omilli F, Deschamps S, Pellerin I (2008) PBX proteins: much more than Hox cofactors. Int J Dev Biol 52:9
19. Maier H, Öfner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623
20. McIntyre DC, Rakshit S, Yallowitz AR, Loken L, Jeannotte L, Capecchi MR, Wellik DM (2007) Hox patterning of the vertebrate rib cage. Development 134:2981-2989
21. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK (2003) Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 63:5879-5888
22. Moens CB, Selleri L (2006) Hox cofactors in vertebrate development. Dev Biol 291:193-206
23. Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS (2012) Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res Treat 136:389-398
24. Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS (2007) Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Res 67:5806
25. Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS (2010) Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer 10:89
26. Plowright L, Harrington K, Pandha H, Morgan R (2009) HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 100:470-475
27. Rich KA, Zhan Y, Blanks JC (1997) Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse. J Neurobiol 32:593-612
28. Shears L, Plowright L, Harrington K, Pandha HS, Morgan R (2008) Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol 180:2196-2201
29. Shears L, Plowright L, Harrington K, Pandha HS, Morgan R (2008) Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol 180:2196-2201
30. Waltregny D, Alami Y, Clausse N, de Leval J, Castronovo V (2002) Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50:162-169
31. Watanabe R, Nakasu Y, Tashiro H, Mitsuya K, Ito I, Nakasu S, Nakajima T (2011) O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma. Brain Tumor Pathol 28:127-135
32. Yaskiv O, Rubin BP, He H, Falzarano S, Magi-Galluzzi C, Zhou M (2012) ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol 138:803-810